Rtn-3 Activators
Rtn-3 Activators belong to a specific chemical class that plays a significant role in cellular biology and molecular research. These compounds are primarily characterized by their ability to modulate the function of Reticulon-3 (Rtn-3), a protein found in the endoplasmic reticulum (ER) membrane of eukaryotic cells. The ER is a crucial organelle responsible for various cellular processes, including protein synthesis, lipid metabolism, and calcium storage. Rtn-3, as a member of the Reticulon family of proteins, participates in shaping and maintaining the ER's distinct morphology, specifically its tubular structures. Rtn-3 Activators are designed to interact with Rtn-3 and influence its activity, thereby impacting the ER's structure and function.
The precise mechanism of Rtn-3 Activators may vary depending on the specific compound, but their fundamental purpose is to modulate the ER's shape and dynamics. This modulation can have far-reaching implications for various cellular processes. By altering the ER's structure, Rtn-3 Activators may indirectly influence protein trafficking, lipid synthesis, and ER stress responses.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, a diterpene, activates adenylyl cyclase, increasing intracellular cAMP levels. This can modulate PKA activity, potentially affecting pathways linked with Rtn-3 regulation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor. By inhibiting MEK, it may alter the MAPK/ERK pathway, which could influence cellular processes and proteins, including possibly Rtn-3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. By inhibiting PI3K, it may affect the AKT pathway, potentially impacting proteins and processes that are involved in the regulation of Rtn-3. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. By modulating this pathway, it may influence cellular responses that could indirectly affect Rtn-3 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is another MEK inhibitor. Its action on the MAPK/ERK pathway could have downstream effects on cellular processes involving Rtn-3. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in cell growth and proliferation. This inhibition might affect pathways or processes that regulate Rtn-3. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor. By influencing the JNK pathway, it may have downstream effects on proteins and processes linked with Rtn-3. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Sunitinib targets multiple receptor tyrosine kinases. Its broad activity might indirectly influence pathways related to Rtn-3. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib inhibits BCR-ABL and c-kit. Its impact on these tyrosine kinases may affect signaling pathways that interact with Rtn-3. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib inhibits proteasome activity. This can lead to altered cellular signaling, potentially affecting pathways involving Rtn-3. | ||||||